Detalhe da pesquisa
1.
Developing Tadpole Xenopus laevis as a Comparative Animal Model to Study Mycobacterium abscessus Pathogenicity.
Int J Mol Sci
; 22(2)2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467397
2.
In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30858221
3.
In Vitro and In Vivo Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 62(8)2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784848
4.
Antiinfectives targeting enzymes and the proton motive force.
Proc Natl Acad Sci U S A
; 112(51): E7073-82, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26644565
5.
2-N-Arylthiazole inhibitors of Mycobacterium tuberculosis.
Bioorg Med Chem Lett
; 27(17): 3987-3991, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28778468
6.
The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.
Antimicrob Agents Chemother
; 59(3): 1534-41, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534740
7.
A novel inhibitor of gyrase B is a potent drug candidate for treatment of tuberculosis and nontuberculosis mycobacterial infections.
Antimicrob Agents Chemother
; 59(3): 1455-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534737
8.
Clinical isolates of Candida albicans, Candida tropicalis, and Candida krusei have different susceptibilities to Co(II) and Cu(II) complexes of 1,10-phenanthroline.
Biometals
; 28(2): 415-23, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25663372
9.
Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria Parasites.
ACS Infect Dis
; 9(2): 342-364, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706233
10.
In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia species.
Antimicrob Agents Chemother
; 56(2): 1133-4, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22106219
11.
Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development.
Microorganisms
; 10(2)2022 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35208914
12.
Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria.
Antibiotics (Basel)
; 10(4)2021 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916775
13.
A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action.
Sci Adv
; 7(5)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571116
14.
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.
Antimicrob Agents Chemother
; 54(8): 3478-80, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516287
15.
Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
Cell Chem Biol
; 26(6): 781-791.e6, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930162
16.
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.
Bioorg Med Chem Lett
; 18(24): 6568-72, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19008098
17.
Therapy for Mycobacterium kansasii Infection: Beyond 2018.
Front Microbiol
; 9: 2271, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30319580
18.
Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis.
PLoS One
; 11(8): e0161740, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27580226
19.
Oxa, Thia, Heterocycle, and Carborane Analogues of SQ109: Bacterial and Protozoal Cell Growth Inhibitors.
ACS Infect Dis
; 1(5): 215-221, 2015 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26258172
20.
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria.
mBio
; 5(1)2014 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24549842